Balance Sheet Data
Dermapharm Holding SE (DMP.DE)
47.14 €
-0.38 (-0.80%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 6.69 | 213.91 | 116.04 | 121.66 | 173.17 | 200.27 | 238.83 | 284.82 | 339.67 | 405.08 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | - | - | - | - | - | - | - | - | - | - |
| Account Receivables (%) | ||||||||||
| Inventories | 81.11 | 115.56 | 172.17 | 203.26 | 240.54 | 254.65 | 303.69 | 362.17 | 431.91 | 515.09 |
| Inventories (%) | ||||||||||
| Accounts Payable | 23.37 | 28.18 | 35.36 | 50.37 | 52.10 | 60.36 | 71.99 | 85.85 | 102.38 | 122.10 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -74.71 | -25.97 | -46.44 | -40.80 | -61.20 | -87.23 | -104.03 | -124.07 | -147.96 | -176.45 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.